Your browser doesn't support javascript.
loading
Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
Ahmad, Imran; Mui, Ernest; Galbraith, Laura; Patel, Rachana; Tan, Ee Hong; Salji, Mark; Rust, Alistair G; Repiscak, Peter; Hedley, Ann; Markert, Elke; Loveridge, Carolyn; van der Weyden, Louise; Edwards, Joanne; Sansom, Owen J; Adams, David J; Leung, Hing Y.
Affiliation
  • Ahmad I; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom; imran.ahmad@glasgow.ac.uk h.leung@beatson.gla.ac.uk.
  • Mui E; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Galbraith L; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Patel R; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Tan EH; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Salji M; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Rust AG; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • Repiscak P; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Hedley A; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom;
  • Markert E; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom;
  • Loveridge C; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • van der Weyden L; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • Edwards J; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom;
  • Sansom OJ; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom;
  • Adams DJ; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom.
  • Leung HY; Cancer Research UK Beatson Institute, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom; imran.ahmad@glasgow.ac.uk h.leung@beatson.gla.ac.uk.
Proc Natl Acad Sci U S A ; 113(29): 8290-5, 2016 07 19.
Article in En | MEDLINE | ID: mdl-27357679
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / PPAR gamma / PTEN Phosphohydrolase / Fatty Acid Synthase, Type I Type of study: Prognostic_studies Limits: Aged / Aged80 / Animals / Humans / Male / Middle aged Language: En Journal: Proc Natl Acad Sci U S A Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / PPAR gamma / PTEN Phosphohydrolase / Fatty Acid Synthase, Type I Type of study: Prognostic_studies Limits: Aged / Aged80 / Animals / Humans / Male / Middle aged Language: En Journal: Proc Natl Acad Sci U S A Year: 2016 Document type: Article